Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. PRTC
PRTC logo

PRTC

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PRTC News

PureTech Health to Participate in Healthcare Conference

Feb 25 2026Businesswire

PureTech Secures Orphan Drug Designation for Deupirfenidone in IPF Treatment

Feb 19 2026Businesswire

PureTech Secures Orphan Drug Designation for LYT-100, Advancing New Treatment Development

Feb 19 2026Newsfilter

Robert Lyne Appointed CEO of PureTech

Dec 18 2025Yahoo Finance

PureTech Appoints Robert Lyne as CEO, Focuses on Funding and Innovation

Dec 18 2025Businesswire

PureTech Appoints Robert Lyne as CEO, Focuses on Funding and Innovation

Dec 18 2025Newsfilter

Meihua International Medical Technologies, Fly-E Group, and Other Major Stocks Decline in Pre-Market Trading on Monday

Dec 08 2025Benzinga

PureTech Completes FDA EOP2 Meeting, Advancing LYT-100 for IPF Treatment

Dec 08 2025Businesswire

PureTech Advances LYT-100 into Phase 3 Clinical Trial Following FDA Feedback

Dec 08 2025Newsfilter

PureTech's Gallop Oncology Reports 13.2-Month Survival with LYT-200 in AML Phase 1b Trial

Dec 05 2025Businesswire

Gallop Oncology's LYT-200 Shows Strong Efficacy with 13.2 Months Survival in AML

Dec 05 2025Newsfilter

PureTech Unveils New Findings from Phase 2b Open-Label Extension Study of Deupirfenidone (LYT-100), Reinforcing Its Strong and Lasting Efficacy as a Potential New Standard Treatment for IPF

Sep 29 2025Newsfilter

CoreWeave, Barrick Mining, FedEx, and Other Major Stocks Rise on Friday

Sep 19 2025Benzinga

Seaport Therapeutics, a PureTech-founded entity, Moves Second Therapeutic Candidate GlyphAgo™ (SPT-320) into Clinical Development with First Participant Dosed in Phase 1 Study Involving Healthy Volunteers

Sep 11 2025Newsfilter

Transcript of PureTech (PRTC) Earnings Call for Q2 2025

Sep 02 2025NASDAQ.COM

Transcript of PureTech Health plc (PRTC) Q2 2025 Earnings Conference Call

Aug 28 2025Newsfilter